SCHEMBL13464716

SCHEMBL13464716

Cc1ccc(C2=NNC(=O)CC2)s1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ PDE3B Q13370 12/20 0.44
▸ PDE3A Q14432 12/20 0.44
▸ PDE4B Q07343 6/20 0.44
▸ PDE4A P27815 5/20 0.44
▸ PDE4C Q08493 5/20 0.44
▸ PDE4D Q08499 5/20 0.44
▸ MAPT P10636 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ NPY1R P25929 1/20 0.42
▸ NPY2R P49146 1/20 0.42
▸ PDE2A O00408 1/20 0.42
▸ PDE1A P54750 1/20 0.42
▸ PDE1B Q01064 1/20 0.42
▸ PDE1C Q14123 1/20 0.42
▸ KCNH2 Q12809 1/20 0.41
▸ KMT2A Q03164 1/20 0.40
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8924482 0.83 SMN1; SMN2 (0.50) SMN1; SMN2PDE3BPDE3APDE4BPDE4A
SCHEMBL10726946 0.75 PDE3B (0.61) SMN1; SMN2PDE3BPDE3APDE4BPDE4A
SCHEMBL10730685 0.73 SMN1; SMN2 (0.38) SMN1; SMN2PDE3BPDE3APDE4BPDE4A
SCHEMBL10650242 0.73 SMN1; SMN2 (0.41) SMN1; SMN2PDE3BPDE3APDE4BPDE4A
SCHEMBL10650666 0.73 PDE3B (0.49) SMN1; SMN2PDE3BPDE3APDE4BPDE4A
SCHEMBL8478610 0.72 GPR119 (0.56) SMN1; SMN2PDE3BPDE3APDE4BPDE4A
SCHEMBL10648684 0.72 SMN1; SMN2 (0.43) SMN1; SMN2PDE3BPDE3APDE4BPDE4A
SCHEMBL10650433 0.72 HRH3 (0.46) SMN1; SMN2PDE3BPDE3APDE4BPDE4A
SCHEMBL10724280 0.72 MAPT (0.38) SMN1; SMN2PDE3BPDE3APDE4BPDE4A
SCHEMBL11035016 0.71 SMN1; SMN2 (0.68) SMN1; SMN2PDE3BPDE3APDE4BPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012142125-A2 PLASMODIAL SURFACE ANION CHANNEL INHIBITORS FOR THE TREATMENT OR PREVENTION OF MALARIA THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2012-10-18 — — WO disclosed
Send feedback